Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Body unavailable. Use the original source.
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.